Medtech Money

Project Medtech
undefined
Apr 15, 2022 • 1h 21min

Episode 69: Hamman de Vaal, Chief Commercial Officer at AdjuCor GmbH | €29 Million Series B: The Power of Investor FOMO & How Western Startups Can Raise Capital from China using Investment Bankers ---

In this episode, our host Giovanni Lauricella and our guest Hamman de Vaal from AdjuCor GmbH discuss what it’s like to work with an investment banker, the uniqueness of raising capital out of china, what it is like being a European Startup, bypassing a traditional series A round, negotiations with China investments, and so much more. Hamman de Vaal LinkedIn AdjuCor GmbH Website Giovanni Lauricella LinkedIn Project Medtech LinkedIn Project Medtech Website
undefined
Apr 13, 2022 • 1h 4min

Episode 68: Catello Somma, Associate at TVM Life Sciences | $478 Million Growth Fund: What Entrepreneurs Don't Known about How Investors Conduct Due Diligence on Startups & How to Build a Pitch Deck

In this episode, our host Giovanni Lauricella and our guest Catello Somma from TVM Life Sciences discuss what goes on behind the scenes once a startup reaches out to an investor, why they do early-stage biotech but late-stage Medtech, slide deck vs. executive summary, the importance of scientific advisory boards, what should entrepreneurs be putting in their slide deck, the due diligence process, who do they call on during their diligence process, and so much more. Catello Somma LinkedIn TVM Life Sciences Website Giovanni Lauricella LinkedIn Project Medtech LinkedIn Project Medtech Website
undefined
Apr 8, 2022 • 57min

Episode 67: Catherine Boule, Managing Partner at Karista | Why Digital Health is Different: European, Early-Stage, Digital Health Fund Invests on the Future for Medtech and Healthtech Converging

In this episode, our host Giovanni Lauricella and our guest Catherine Boule from Karista discuss why 100% of their business plans are wrong and why this is normal for the stage of company they are investing in, where and who they invest in, what they would like to do in their next fund, their focus on digital health, challenges startups face, why they only focus on France and Western Europe, the converging and merging of Medtech and Digital health and so much more. Catherine Boule LinkedIn Karista Website Giovanni Lauricella LinkedIn Project Medtech LinkedIn Project Medtech Website
undefined
Apr 6, 2022 • 56min

Episode 66: Graeme Smith, CEO at Lightpoint Medical | Equity and Debt Series C-2: Common Shares for All Investors & Hired CEO for Confidence, Commercialization, and Sustainability

In this episode, our host Giovanni Lauricella and our guest Graeme Smith from Lightpoint Medical discuss leading a commercial stage Medtech company, taking over a startup with a goal of exiting to a strategic or going public, his experience with Cancer and the problem that they are trying to solve, the relationship with Medtech distributors, the reason for calling it a Series C1 and Series C2, the dynamic between Graeme and the previous CEO, the valuation of a pre-revenue Medtech company, working towards his 6th exit, and so much more. Graeme Smith LinkedIn Lightpoint Medical Website Giovanni Lauricella LinkedIn Project Medtech LinkedIn Project Medtech Website
undefined
Apr 1, 2022 • 1h 14min

Episode 65: Andreas Forsland, Founder & CEO at Cognixion | $12 Million Seed Round: The Convergence of Medtech, DeepTech, and ConsumerTech

In this episode, our host Giovanni Lauricella and our guest Andreas Forsland from Cognixion discuss how innovating at a startup vs. a large Medtech player differ, the intersection of Medtech, Deeptech, and Consumer Tech, his motivation for why he founded Cognixion, their goal of 100 million voices unlocked, the metaverse and Web 3.0, product adoption in high-tech spaces, raising capital for the first time and his very first steps, getting venture dollars first and then non-dilutive capital, why they opened up in Canada, why the seed round was so large,  and so much more. Andreas Forsland LinkedIn Cognixion Website Giovanni Lauricella LinkedIn Project Medtech LinkedIn Project Medtech Website
undefined
Mar 30, 2022 • 57min

Episode 64: Renee Ryan, CEO at Cala Health | Raising $77 Million as a First-Time CEO: How an Investment Banker became a Corporate Venture Investor who turned to Entrepreneurship

In this episode, our host Giovanni Lauricella and our guest Renee Ryan from Cala Health discuss her background in investment banking, her transition to an investor, what they are working on at Cala Health, working with a board, closing their financing rounds, best advice for startup companies, and so much more. Renee Ryan LinkedIn Cala Health Website Giovanni Lauricella LinkedIn Project Medtech LinkedIn Project Medtech Website
undefined
Mar 26, 2022 • 1h 7min

Episode 63: David Suendermann-Oeft, Co-Founder & CEO at Modality.AI | Raising Capital for SaMD: Team, Accelerators, Global Investor Syndicates, Delaware C-Corps, and Importance of "Investor Fit"

In this episode, our host Giovanni Lauricella and our guest David Suendermann-Oeft from Modality.AI discuss what the transition was like going from academia to startup CEO, what problem his company is solving, raising capital as software as a medical device, the time it took to close the $2.1 million round, their experience with raising early-stage money, what type of investors were in their early rounds, and so much more. David Suendermann-Oeft LinkedIn Modality.AI Website Giovanni Lauricella LinkedIn Project Medtech LinkedIn Project Medtech Website
undefined
Mar 23, 2022 • 1h 5min

Episode 62: Soumya Mahapatra, Co-Founder & CEO at Essenvia | Medtech SaaS, Startups, and SAFEs: How a First-Time Entrepreneur Raised a $1.4 million Seed Round in Two Weeks

In this episode, our host Giovanni Lauricella and our guest Soumya Mahapatra from Essenvia discuss what it is like to be a Co-Founder & CEO, the problem they are solving at Essenvia, SAFEs vs. Convertible note vs. Priced equity rounds, family and friends round for SaaS, how he closed a round in two weeks from his first check, why he did due diligence on his investors, and so much more. Soumya Mahapatra LinkedIn Essenvia Website Giovanni Lauricella LinkedIn Project Medtech LinkedIn Project Medtech Website
undefined
Mar 19, 2022 • 1h 2min

Episode 61: Manuel Opitz, Co-Founder & CEO at Deepeye GmbH | Software vs. Hardware and the Two-Way Street: How CEOs Save Time Raising Capital By Doing Due Diligence on Investors

In this episode, our host Giovanni Lauricella and our guest Manuel Opitz from Deepeye discuss the importance of people when forming a Medtech startup, what they are working on at Deepeye, the advantages and disadvantages of MDR, his lessons learned while raising capital, the differences in traditional Medtech and software when raising money, the importance of doing due diligence on your investors, and so much more. Manuel Opitz LinkedIn Deepeye GmbH Website Giovanni Lauricella LinkedIn Project Medtech LinkedIn Project Medtech Website
undefined
Mar 16, 2022 • 60min

Episode 60: Antoine Papiernik, Chairman & Managing Partner at Sofinnova Partners | Think Big with "What if They Are Right?": Love for Medtech and Sofinnova's 50th Anniversary with €2,5 Billion AUM

In this episode, our host Giovanni Lauricella and our guest Antoine Papiernik at Sofinnova Partners discuss the grit and time it takes to be a successful venture capital investor, his background with Sofinnova, what Sofinnova does and where they invest, why he invests in Medtech, Why Shockwave is his #1 Medtech story, the major differences between US and European investors, his thoughts on the MDR, the shift we are going to see in investors from around the globe looking at Medtech companies, why Sofinnova stands out, their most recent $548 million early-stage healthcare fund, and so much more. Antoine Papiernik LinkedIn Sofinnova Website Giovanni Lauricella LinkedIn Project Medtech LinkedIn Project Medtech Website

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app